179 related articles for article (PubMed ID: 11501723)
1. Pain and pain relief in fibromyalgia patients followed for three years.
Pöyhiä R; Da Costa D; Fitzcharles MA
Arthritis Rheum; 2001 Aug; 45(4):355-61. PubMed ID: 11501723
[TBL] [Abstract][Full Text] [Related]
2. Factors that affect the number of tender points in fibromyalgia and chronic widespread pain patients who did not meet the ACR 1990 criteria for fibromyalgia: are tender points a reflection of neuropathic pain?
Pamuk ON; Yeşil Y; Cakir N
Semin Arthritis Rheum; 2006 Oct; 36(2):130-4. PubMed ID: 16884973
[TBL] [Abstract][Full Text] [Related]
3. Problem elicitation to assess patient priorities in ankylosing spondylitis and fibromyalgia.
Bakker C; van der Linden S; van Santen-Hoeufft M; Bolwijn P; Hidding A
J Rheumatol; 1995 Jul; 22(7):1304-10. PubMed ID: 7562763
[TBL] [Abstract][Full Text] [Related]
4. Fibromyalgia versus rheumatoid arthritis: a longitudinal comparison of the quality of life.
Martinez JE; Ferraz MB; Sato EI; Atra E
J Rheumatol; 1995 Feb; 22(2):270-4. PubMed ID: 7738950
[TBL] [Abstract][Full Text] [Related]
5. Osteopathic manipulative treatment in conjunction with medication relieves pain associated with fibromyalgia syndrome: results of a randomized clinical pilot project.
Gamber RG; Shores JH; Russo DP; Jimenez C; Rubin BR
J Am Osteopath Assoc; 2002 Jun; 102(6):321-5. PubMed ID: 12090649
[TBL] [Abstract][Full Text] [Related]
6. Arginase, NOS activities, and clinical features in fibromyalgia patients.
Cimen OB; Cimen MY; Yapici Y; Camdeviren H
Pain Med; 2009; 10(5):813-8. PubMed ID: 19523030
[TBL] [Abstract][Full Text] [Related]
7. Number of fibromyalgia tender points is associated with health status in patients with systemic lupus erythematosus.
Akkasilpa S; Goldman D; Magder LS; Petri M
J Rheumatol; 2005 Jan; 32(1):48-50. PubMed ID: 15630724
[TBL] [Abstract][Full Text] [Related]
8. Relationships between the fibromyalgia impact questionnaire, tender point count, and muscle strength in female patients with fibromyalgia: a cohort study.
Henriksen M; Lund H; Christensen R; Jespersen A; Dreyer L; Bennett RM; Danneskiold-Samsøe B; Bliddal H
Arthritis Rheum; 2009 Jun; 61(6):732-9. PubMed ID: 19479709
[TBL] [Abstract][Full Text] [Related]
9. Responsiveness of fibromyalgia clinical trial outcome measures.
Dunkl PR; Taylor AG; McConnell GG; Alfano AP; Conaway MR
J Rheumatol; 2000 Nov; 27(11):2683-91. PubMed ID: 11093454
[TBL] [Abstract][Full Text] [Related]
10. Neurophysiologic evidence for a central sensitization in patients with fibromyalgia.
Desmeules JA; Cedraschi C; Rapiti E; Baumgartner E; Finckh A; Cohen P; Dayer P; Vischer TL
Arthritis Rheum; 2003 May; 48(5):1420-9. PubMed ID: 12746916
[TBL] [Abstract][Full Text] [Related]
11. Fibromyalgia syndrome in children--an outcome study.
Buskila D; Neumann L; Hershman E; Gedalia A; Press J; Sukenik S
J Rheumatol; 1995 Mar; 22(3):525-8. PubMed ID: 7783074
[TBL] [Abstract][Full Text] [Related]
12. Effects of low power laser and low dose amitriptyline therapy on clinical symptoms and quality of life in fibromyalgia: a single-blind, placebo-controlled trial.
Gür A; Karakoc M; Nas K; Cevik R; Sarac J; Ataoglu S
Rheumatol Int; 2002 Sep; 22(5):188-93. PubMed ID: 12215864
[TBL] [Abstract][Full Text] [Related]
13. Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize ra patients with fibromyalgia.
Wolfe F; Michaud K
J Rheumatol; 2004 Apr; 31(4):695-700. PubMed ID: 15088293
[TBL] [Abstract][Full Text] [Related]
14. The role of IL-8 in patients with fibromyalgia: a prospective longitudinal study of 6 months.
Wang H; Buchner M; Moser MT; Daniel V; Schiltenwolf M
Clin J Pain; 2009 Jan; 25(1):1-4. PubMed ID: 19158539
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.
Holman AJ; Myers RR
Arthritis Rheum; 2005 Aug; 52(8):2495-505. PubMed ID: 16052595
[TBL] [Abstract][Full Text] [Related]
16. Aspects of diurnal rhythmicity in pain, stiffness, and fatigue in patients with fibromyalgia.
Bellamy N; Sothern RB; Campbell J
J Rheumatol; 2004 Feb; 31(2):379-89. PubMed ID: 14760811
[TBL] [Abstract][Full Text] [Related]
17. C2 area neurostimulation: a surgical treatment for fibromyalgia.
Thimineur M; De Ridder D
Pain Med; 2007; 8(8):639-46. PubMed ID: 18028042
[TBL] [Abstract][Full Text] [Related]
18. Nonphysician practitioner treatments and fibromyalgia syndrome.
Fitzcharles MA; Esdaile JM
J Rheumatol; 1997 May; 24(5):937-40. PubMed ID: 9150085
[TBL] [Abstract][Full Text] [Related]
19. Anti-polymer antibodies are correlated with pain and fatigue severity in patients with fibromyalgia syndrome.
Sarzi-Puttini P; Atzeni F; Di Franco M; Lama N; Batticciotto A; Iannuccelli C; Dell'Acqua D; de Portu S; Riccieri V; Carrabba M; Buskila D; Doria A; Valesini G
Autoimmunity; 2008 Feb; 41(1):74-9. PubMed ID: 18176867
[TBL] [Abstract][Full Text] [Related]
20. Does the label "fibromyalgia" alter health status, function, and health service utilization? A prospective, within-group comparison in a community cohort of adults with chronic widespread pain.
White KP; Nielson WR; Harth M; Ostbye T; Speechley M
Arthritis Rheum; 2002 Jun; 47(3):260-5. PubMed ID: 12115155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
